Journal
CLINICA CHIMICA ACTA
Volume 388, Issue 1-2, Pages 51-58Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2007.10.005
Keywords
autotaxin; lysophospholipase D; lysophosphatidic acid; enzyme immunoassay; serum; hypoalbuminemia
Categories
Ask authors/readers for more resources
Backgroun: Autotaxin (ATX), a tumor cell motility-stimulating factor, regulates the blood concentrations of lysophosphatidic acid (LPA), an important and multi-functional bioactive lipid, through its lysophospholipase D activity (lysoPLD). The introduction of ATX measurements into clinical laboratory testing is urgently needed. Methods: Anti-human ATX monoclonal antibodies were produced by immunization of recombinant human ATX expressed in a baculovirus system. An inummoassay for the quantitative determination of ATX was established, and human serum samples were assayed. Results: The within-run and between-run precision, interference, detection limit, and linearity studies were satisfactory. The central 95 percentile reference interval for the serum ATX antigen concentration in healthy subjects was 0.468-1.134 mg/l (n = 120) and was strongly corrleated with the serum lysoPLD activity., The ATX concentration was significantly (p<0.001) higher in women (0.625-1.323 mg/l) than in men (0.438-0.914 mg/l). The serum ATX concentrations were increased in patients with chronic liver diseases and decreased in postoperative prostate cancer patients but were not altered in nephrosis patients. Thus, serum ATX antigen concentrations could be used to discriminate these hypoalbuminemia conditions. Conclusions: The present ATX antigen assay may be useful for clinical laboratory testing. (c) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available